HU0004543D0 - - Google Patents

Info

Publication number
HU0004543D0
HU0004543D0 HU0004543A HUP0004543A HU0004543D0 HU 0004543 D0 HU0004543 D0 HU 0004543D0 HU 0004543 A HU0004543 A HU 0004543A HU P0004543 A HUP0004543 A HU P0004543A HU 0004543 D0 HU0004543 D0 HU 0004543D0
Authority
HU
Hungary
Prior art keywords
alkyl
aryl
cyclopropylhydrocarbylamino
heteroarylene
alkoxy
Prior art date
Application number
HU0004543A
Other languages
Hungarian (hu)
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of HU0004543D0 publication Critical patent/HU0004543D0/hu
Publication of HUP0004543A2 publication Critical patent/HUP0004543A2/en
Publication of HUP0004543A3 publication Critical patent/HUP0004543A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/40Nitrogen atoms, not forming part of a nitro radical, e.g. isatin semicarbazone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

2-Cyclopropylhydrocarbylamino-pyrrolidine derivatives (I) are new. 2-Cyclopropylhydrocarbylamino-pyrrolidine derivatives of formula (I) and their isomers and salts are new: n = 1 or 2; X = 1-6C alkylene, 2-6C alkenylene (containing 1-3 double bonds), 2-6C alkynylene (containing 1-3 triple bonds) or optionally Q-substituted arylene or heteroarylene; R10, R12 = H or 1-6C alkyl; R11 = H; or R10+R11 or R11+R12 = a bond; R2-R4 = H, 1-6C alkyl, 1-6C hydroxyalkyl, 1-6C alkoxy, 2-7C alkoxycarbonyl or optionally Q-substituted aryl, aryl(1-6C)alkyl or aryloxy(1-6C)alkyl, or two of R2-R4 form a 5-7C cycloalkane ring; Q = halogen, 1-6C alkyl, 1-6C alkoxy, OH, CN, NO2, NH2 and/or mono- or di(1-6C alkyl)amino; aryl = phenyl or naphthyl; arylene = phenylene or naphthylene; and heteroaryl and heteroarylene = 4- to 11-membered mono- or bicyclic saturated or partially unsaturated groups containing 1-5 heteroatoms selected from N, O and S. An Independent claim is also included for a process for preparing compounds (I).
HU0004543A 1999-11-17 2000-11-16 Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them HUP0004543A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9914434A FR2801051B1 (en) 1999-11-17 1999-11-17 NOVEL AMINOPYRROLINE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

Publications (3)

Publication Number Publication Date
HU0004543D0 true HU0004543D0 (en) 2001-02-28
HUP0004543A2 HUP0004543A2 (en) 2001-10-28
HUP0004543A3 HUP0004543A3 (en) 2001-11-28

Family

ID=9552203

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004543A HUP0004543A3 (en) 1999-11-17 2000-11-16 Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6300366B1 (en)
EP (1) EP1101756B1 (en)
JP (1) JP3274456B2 (en)
KR (1) KR100453981B1 (en)
CN (1) CN1158257C (en)
AT (1) ATE234815T1 (en)
AU (1) AU771745B2 (en)
BR (1) BR0005442A (en)
CA (1) CA2325781C (en)
DE (1) DE60001706T2 (en)
DK (1) DK1101756T3 (en)
EA (1) EA004042B1 (en)
ES (1) ES2194691T3 (en)
FR (1) FR2801051B1 (en)
HK (1) HK1036454A1 (en)
HU (1) HUP0004543A3 (en)
MX (1) MXPA00011239A (en)
NO (1) NO317987B1 (en)
NZ (1) NZ508228A (en)
PL (1) PL343920A1 (en)
PT (1) PT1101756E (en)
SI (1) SI1101756T1 (en)
ZA (1) ZA200006731B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL372695A1 (en) 2002-06-19 2005-07-25 Solvay Pharmaceuticals Gmbh Medicament for the treatment of diseases requiring inhibition or a reduction in the activity of ph value-regulating bicarbonate transporter proteins
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
IL280864B2 (en) 2013-08-09 2024-03-01 Ardelyx Inc Compounds and methods for inhibiting phosphate transport
GB201318886D0 (en) * 2013-10-25 2013-12-11 Givaudan Sa Improvements i or relating to organic compounds
CN114716359B (en) * 2022-04-28 2023-01-17 广东医科大学 Preparation method of hydrogenated indole imine diastereoisomer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2029297A1 (en) * 1970-06-13 1971-12-30 Farbenfabriken Bayer Ag, 5090 Leverkusen New aminophenyl-cycloamidines, processes for their production and their use as pharmaceuticals
US3887569A (en) * 1970-10-30 1975-06-03 Mcneilab Inc 2-Imino-piperidines
NL7412695A (en) * 1974-09-26 1976-03-30 Stamicarbon THE PREPARATION OF A 2-AMINO-PYRROLIN DERIVATIVE.
US4579951A (en) * 1984-03-19 1986-04-01 G. D. Searle & Co. Substituted (azacycloalk-2-yl)iminophenols and esters thereof
DE4425070A1 (en) * 1994-07-15 1996-01-18 Degussa Process for the preparation of optically active l-substituted 2- (aminomethyl) pyrrolidines

Also Published As

Publication number Publication date
US6300366B1 (en) 2001-10-09
KR20010051776A (en) 2001-06-25
HUP0004543A3 (en) 2001-11-28
EP1101756A1 (en) 2001-05-23
CA2325781C (en) 2006-07-18
AU7168000A (en) 2001-05-24
PT1101756E (en) 2003-06-30
MXPA00011239A (en) 2002-05-23
SI1101756T1 (en) 2003-06-30
EP1101756B1 (en) 2003-03-19
ATE234815T1 (en) 2003-04-15
JP3274456B2 (en) 2002-04-15
CN1298872A (en) 2001-06-13
ZA200006731B (en) 2001-05-30
HUP0004543A2 (en) 2001-10-28
FR2801051A1 (en) 2001-05-18
CN1158257C (en) 2004-07-21
PL343920A1 (en) 2001-05-21
EA200001077A2 (en) 2001-06-25
EA004042B1 (en) 2003-12-25
DK1101756T3 (en) 2003-07-14
ES2194691T3 (en) 2003-12-01
BR0005442A (en) 2001-07-03
NZ508228A (en) 2001-03-30
NO20005797D0 (en) 2000-11-16
KR100453981B1 (en) 2004-10-20
JP2001139545A (en) 2001-05-22
EA200001077A3 (en) 2001-08-27
CA2325781A1 (en) 2001-05-17
DE60001706T2 (en) 2004-02-05
DE60001706D1 (en) 2003-04-24
HK1036454A1 (en) 2002-01-04
FR2801051B1 (en) 2001-12-14
NO317987B1 (en) 2005-01-17
AU771745B2 (en) 2004-04-01
NO20005797L (en) 2001-05-18

Similar Documents

Publication Publication Date Title
KR950014097A (en) Piperazine Derivatives
HRP20020223C1 (en) Triphenylalkene derivatives and their use as selective estrogen receptor modulators
HU0004543D0 (en)
HK1063322A1 (en) 1-Glyoxlylamide indolizines for treating cancer.
HUP0303361A2 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
DK1103554T3 (en) Dihydrofuro [3,4-b] quinolein-1-derivatives, process for their preparation and pharmaceutical compositions containing them
BG106937A (en) Novel indole derivatives
MXPA04005837A (en) Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same.
HUP0301008A2 (en) New imidazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
TW200510309A (en) Chemical compounds
HU9802645D0 (en) New metalloproteinase inhibitors, process for producing them, and pharmaceutical compositions containing them
BG106048A (en) 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof
UA72934C2 (en) Phenyl - and piperidyl tetrahydropiridines inhibiting tumors necrosis factor, a method for preparing thereof and pharmaceutical composition
DK0841337T3 (en) Substituted 7,12-dioxabenzo [a] anthracene derivatives, processes for their preparation and pharmaceutical compositions containing these derivatives
DK48188D0 (en) ERGOLINYL-HETEROCYCLIC COMPOUNDS AND PROCEDURES FOR PREPARING THEREOF
PL334624A1 (en) Novel compounds of 8h-thiene-/2,3-b/pyrolysin-8-one, method of obtaining them and pharmaceutic compositions containing such compounds